Plus Therapeutics (PSTV) Other Working Capital Changes (2016 - 2025)
Plus Therapeutics has reported Other Working Capital Changes over the past 14 years, most recently at -$12000.0 for Q4 2025.
- Quarterly Other Working Capital Changes rose 90.08% to -$12000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$66000.0 through Dec 2025, up 69.72% year-over-year, with the annual reading at -$66000.0 for FY2025, 69.72% up from the prior year.
- Other Working Capital Changes was -$12000.0 for Q4 2025 at Plus Therapeutics, down from -$9000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $424000.0 in Q3 2022 and troughed at -$459000.0 in Q1 2022.
- The 5-year median for Other Working Capital Changes is -$29000.0 (2023), against an average of -$21176.5.
- The largest YoY upside for Other Working Capital Changes was 867.74% in 2024 against a maximum downside of 585.19% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $170000.0 in 2021, then tumbled by 116.47% to -$28000.0 in 2022, then fell by 7.14% to -$30000.0 in 2023, then crashed by 303.33% to -$121000.0 in 2024, then surged by 90.08% to -$12000.0 in 2025.
- Per Business Quant, the three most recent readings for PSTV's Other Working Capital Changes are -$12000.0 (Q4 2025), -$9000.0 (Q3 2025), and $29000.0 (Q2 2025).